Navigation Links
Anemia Drugs to Be Taken With Caution

A trial of Aranesp an anemia drug from Amgen Inc disclosed a rise in number of deaths especially in advanced cancer patients. This has reiterated the fact// that such drugs should be prescribed in restricted conditions only.

The mode of action of Aranesp is based on the natural protein called erythropoietin (EPO) which augments the production of red blood corpuscles in the body. This drug is the major product of Amgen Inc and has also been permitted to treat in conditions of anemia caused by chemotherapy and renal failure patients.

According to Roger Perlmutter, Amgen Inc.’s Executive Vice President for Research and Development, this drug if used within the specified indications is bound to be safe.

Generally EPO drugs are meant for people undertaking chemotherapy or radiation. But as per Amgen, this drug has also been prescribed for patients who are not undergoing chemotherapy or radiation.

Hence clear information on the conditions in which these EPO drugs to be used would surely benefit the patient and the health care community.


JYT
'"/>




Page: 1

Related medicine news :

1. Anemia may Lead to Physical Decline
2. Anemia Treatment for Cancer Patients
3. Anemia Treatment for Cancer Patients
4. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
5. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
6. Treatment of Sickle Cell Anemia Using Gene Therapy.
7. Treating Sickle Cell Anemia using Healthy Stem Cells
8. Anemia from Malaria Linked to a Protein MIF
9. EPO Effective For Cancer Patients Suffering From Anemia
10. Amgen introduces Autoinjector For Treating Anemia
11. Anemia Affects Both Body and Mind
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 ... ... featuring an inspirational interview of two ostomy patients, standing as living proof that ... people suffer from digestive diseases and issues that spike around the holidays. This ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference ... and Spa in Honolulu, offering local frontline clinicians the opportunity to extend their ... The demand for supplemental training related to pain management has surged dramatically in ...
(Date:12/2/2016)... , ... December 02, 2016 , ... "Pro3rd Accents Volume ... editors to create versatile lower third titles with just a few clicks of the ... Volume 2 includes 30 lower third animations. Choose from various styles with accented animations, ...
(Date:12/2/2016)... FL (PRWEB) , ... December 02, 2016 , ... ‘Tis ... are winners of $1,000 each from the National Family Partnership and the Drug Enforcement ... families who decorated their homes and the 10 winning schools who decorated their campuses ...
(Date:11/30/2016)... Beach Gardens, FL (PRWEB) , ... November 30, ... ... in eating disorder and mental health treatment has announced the opening of a ... provides specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, both ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... , Dec. 2, 2016   CytoSorbents Corporation ... commercializing its European Union approved CytoSorb ® cytokine ... surgery patients worldwide, announced that Dr. Phillip Chan ... 9th Annual LD Micro Main Event investor conference ... at the Luxe Sunset Boulevard Hotel in ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended the trading ... edged 0.36% higher, to finish at 19,191.93; and the S&P ... as six out of nine sectors ended the day in ... Services equities: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Inc. (NASDAQ: INCR ), and La Quinta Holdings ...
Breaking Medicine Technology: